Openbookopenbook
Equity
IRMD
+0.0 · +0.00%
USD · NASDAQ

Iradimed Co(IRMD) Stock Analysis | Healthcare

USD --+0.00%
Reward67High
Risk30Moderate
75%Data
Strong 27% profit margin
Quality Compounder
Market Cap:1.12Bn
ⓘ
Reward Rating
67
High
Reward Assessment
75% data coverage
Top 25% of stocksView factors
ⓘ
Risk Rating
30
Moderate
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on IRMD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for IRMD, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $118.00.

What is Iradimed Co?

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.

IRMD · Verdict

Solid reward · low risk

IRMD stands out on cash flow and balance sheet, but watch the valuation signal.

Based on 88% data coverage

IRMD · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow95/100

    21% free-cash-flow margin

  • Balance sheet93/100

    Current ratio 7.98

  • Profitability90/100

    27% net margin · 24% ROE

  • Growth85/100

    Rev +16.3% CAGR · earnings +20.6%

Watchouts 1

  • Valuation18/100

    P/E 41.2× · PEG 4.46

Model-based scoring. For information only — not financial advice.

What is Iradimed Co?

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.12B, and a P/E ratio of 49.1x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Strong margins and consistent earnings support financial stability.
Risk
Below-average volatility supports a steadier risk profile.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

LMRISmall Cap / 1.2B market cap
Lumexa Imaging Holdings, Inc. Common Stock
Compare
AVNSSmall Cap / 1.2B market cap
Avanos Medical Inc
Compare
LFTSFSmall Cap / 1B market cap
LifeTech Scientific Corporation
Compare
Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap1.12B
P/E Ratio49.0782
Dividend Yield0.89%
Beta0.91
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
1245,000 shares
$4.4M
0
6-9months
745,000 shares
$4.4M
0
9-12months
15,000 shares
$452k
0
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.